A comprehensive literature review finds that the Biodesix VeriStrat test can aid in more precise treatment prognosis to inform treatment choice for patients with non-small cell lung cancer.
Read More
Patients with early-stage non-small cell lung cancer receive significantly different treatments based on the results of VeriStrat testing.
Read More
The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.
Read More
New probes facilitate the diagnosis and stratified treatment of non-small cell lung cancer.
Read MoreAn international group of lung cancer experts has announced the public comment period for a revised guideline on molecular testing to improve patient selection and targeted therapies.
Read More